BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30464547)

  • 21. Outcomes after Surgery among Patients Diagnosed with One or More Multi-Drug-Resistant Organisms.
    Gupta A; Tennakoon L; Spain DA; Forrester JD
    Surg Infect (Larchmt); 2021 Sep; 22(7):722-729. PubMed ID: 33471591
    [No Abstract]   [Full Text] [Related]  

  • 22. Bacteremia in Patients With Liver Cirrhosis: Prevalence and Predictors of Multidrug Resistant Organisms.
    Addo Smith JN; Yau R; Russo HP; Putney K; Restrepo A; Garey KW; Sofjan AK
    J Clin Gastroenterol; 2018 Aug; 52(7):648-654. PubMed ID: 29176351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Screening of Risk for Multidrug-Resistant Organisms in the Emergency Department in Patients With Pneumonia and Early Septic Shock: Single-Center, Retrospective Cohort Study.
    Yiang GT; Tzeng IS; Shui HA; Wu MY; Peng MY; Chan CY; Chan ED; Wu YK; Lan CC; Yang MC; Huang KL; Wu CW; Chang CH; Su WL
    Shock; 2021 Feb; 55(2):198-209. PubMed ID: 32694392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission.
    Gupta T; Lochan D; Verma N; Rathi S; Agrawal S; Duseja A; Taneja S; Chawla YK; Dhiman RK
    J Gastroenterol Hepatol; 2020 Mar; 35(3):461-466. PubMed ID: 31334860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.
    Magira EE; Islam S; Niederman MS
    Med Intensiva (Engl Ed); 2018 May; 42(4):225-234. PubMed ID: 29033075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and evaluation of the automated risk assessment system for multidrug-resistant organisms (autoRAS-MDRO).
    Hur EY; Jin YJ; Jin TX; Lee SM
    J Hosp Infect; 2018 Feb; 98(2):202-211. PubMed ID: 28807836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EVALUATION OF PROGNOSTIC FACTORS IN DECOMPENSATED LIVER CIRRHOSIS WITH ASCITES AND SPONTANEOUS BACTERIAL PERITONITIS.
    Dănulescu RM; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1018-24. PubMed ID: 26793843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the patterns and microbiology of spontaneous bacterial peritonitis : analysis of 200 cirrhotic patients.
    Al-Ghamdi H; Al-Harbi N; Mokhtar H; Daffallah M; Memon Y; Aljumah AA; Sanai FM
    Acta Gastroenterol Belg; 2019; 82(2):261-266. PubMed ID: 31314186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiota-associated risk factors for asymptomatic gut colonisation with multi-drug-resistant organisms in a Dutch nursing home.
    Ducarmon QR; Terveer EM; Nooij S; Bloem MN; Vendrik KEW; Caljouw MAA; Sanders IMJG; van Dorp SM; Wong MC; Zwittink RD; Kuijper EJ
    Genome Med; 2021 Apr; 13(1):54. PubMed ID: 33827686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
    Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
    J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma.
    Himmelsbach V; Knabe M; Ferstl PG; Peiffer KH; Stratmann JA; Wichelhaus TA; Hogardt M; Kempf VAJ; Zeuzem S; Waidmann O; Finkelmeier F; Ballo O
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1465-1472. PubMed ID: 34283288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis.
    Friedrich K; Nüssle S; Rehlen T; Stremmel W; Mischnik A; Eisenbach C
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1191-5. PubMed ID: 26676553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis.
    Mo S; Bendtsen F; Wiese SS; Kimer N
    Scand J Gastroenterol; 2018 Feb; 53(2):200-205. PubMed ID: 29214880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of a Multicomponent Intervention to Reduce Multidrug-Resistant Organisms in Nursing Homes: A Cluster Randomized Clinical Trial.
    Mody L; Gontjes KJ; Cassone M; Gibson KE; Lansing BJ; Mantey J; Kabeto M; Galecki A; Min L
    JAMA Netw Open; 2021 Jul; 4(7):e2116555. PubMed ID: 34269807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Healthcare associated infections (HAI), antibiotic use and prevalence of multidrug-resistant bacteria (MDRO) in residents of long-term care facilities: the Frankfurt HALT plus MDRO project 2012].
    Heudorf U; Gustav C; Mischler D; Schulze J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Apr; 57(4):414-22. PubMed ID: 24658671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.
    Shizuma T
    World J Hepatol; 2018 Feb; 10(2):254-266. PubMed ID: 29527261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of spontaneous bacterial peritonitis in liver cirrhosis with ascites.
    Oladimeji AA; Temi AP; Adekunle AE; Taiwo RH; Ayokunle DS
    Pan Afr Med J; 2013; 15():128. PubMed ID: 24255734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis.
    Verma N; Divakar Reddy PV; Vig S; Angrup A; Biswal M; Valsan A; Garg P; Kaur P; Rathi S; De A; Premkumar M; Taneja S; Ray P; Duseja A; Singh V
    JHEP Rep; 2023 Aug; 5(8):100788. PubMed ID: 37484213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms.
    Wang J; Foxman B; Mody L; Snitkin ES
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10467-10472. PubMed ID: 28900004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of risk factors associated with multidrug-resistant organism infections among patients admitted in a tertiary hospital - a retrospective study.
    Alsehemi AF; Alharbi EA; Alammash BB; Alrais AI; Elbadawy HM; Alahmadi YM
    Saudi Pharm J; 2023 Jun; 31(6):1084-1093. PubMed ID: 37293381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.